Skip to main content
Premium Trial:

Request an Annual Quote

CareDx: Minetta Liu

Natera appointed Minetta Liu as its new chief medical officer of oncology, tasked with proving Signatera's clinical utility and incorporating it into standard practice. Liu previously served as professor of oncology and chair of research at the Mayo Clinic in Rochester, NY, where she also co-led the Genomics in Action Strategic Priority for the Center of Individualized Medicine. Additionally, Liu has chaired the Circulating Biomarker Working Group of the Alliance for Clinical Trials in Oncology and has co-chaired the Correlative Science Working Group of the Translational Breast Cancer Research Consortium.